JP2016528174A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016528174A5 JP2016528174A5 JP2016517040A JP2016517040A JP2016528174A5 JP 2016528174 A5 JP2016528174 A5 JP 2016528174A5 JP 2016517040 A JP2016517040 A JP 2016517040A JP 2016517040 A JP2016517040 A JP 2016517040A JP 2016528174 A5 JP2016528174 A5 JP 2016528174A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- cdp
- conjugate
- jak inhibitor
- jak
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361829797P | 2013-05-31 | 2013-05-31 | |
| US61/829,797 | 2013-05-31 | ||
| PCT/US2014/040230 WO2014194195A2 (en) | 2013-05-31 | 2014-05-30 | Cyclodextrin-based polymers for the therapeutic delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016528174A JP2016528174A (ja) | 2016-09-15 |
| JP2016528174A5 true JP2016528174A5 (enExample) | 2017-07-13 |
Family
ID=51985801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016517040A Pending JP2016528174A (ja) | 2013-05-31 | 2014-05-30 | 治療的送達用のシクロデキストリンベースのポリマー |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20140357557A1 (enExample) |
| JP (1) | JP2016528174A (enExample) |
| AU (1) | AU2014273983A1 (enExample) |
| CA (1) | CA2913752A1 (enExample) |
| WO (1) | WO2014194195A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105924444B (zh) * | 2015-03-11 | 2019-06-18 | 苏州晶云药物科技股份有限公司 | Jak抑制剂的晶型及其制备方法 |
| CN104987333B (zh) * | 2015-07-14 | 2017-01-11 | 苏州富士莱医药股份有限公司 | 一种Filgotinib的合成方法 |
| EP3355891B1 (en) * | 2015-09-28 | 2021-01-13 | CTI Biopharma Corp. | Pacritinib for use in treating transplant rejection |
| CN108472308A (zh) * | 2015-10-20 | 2018-08-31 | 埃默里大学 | 应答指导型hcv疗法 |
| US10435428B2 (en) | 2015-11-24 | 2019-10-08 | Theravance Biopharma R&D Ip, Llc | Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease |
| WO2017177055A1 (en) * | 2016-04-08 | 2017-10-12 | Liang Zhao | Cyclodextrin-based polymers for therapeutic delivery |
| CN110072519A (zh) * | 2016-12-14 | 2019-07-30 | 普罗根尼蒂公司 | 使用jak抑制剂治疗胃肠道疾病及装置 |
| WO2018165250A1 (en) * | 2017-03-08 | 2018-09-13 | Theravance Biopharma R&D Ip, Llc | Glucuronide prodrugs of tofacitinib |
| AU2018236465A1 (en) * | 2017-03-16 | 2019-08-22 | Blaze Bioscience, Inc. | Cartilage-homing peptide conjugates and methods of use thereof |
| EP3609903A1 (en) * | 2017-05-23 | 2020-02-19 | Theravance Biopharma R&D IP, LLC | Thiocarbamate prodrugs of tofacitinib |
| JP2020520955A (ja) | 2017-05-23 | 2020-07-16 | セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー | ヤヌスキナーゼ阻害剤のグルクロニドプロドラッグ |
| CA3081802A1 (en) | 2017-11-03 | 2019-05-09 | Osteoanalgesia, Llc | Drug delivery system for treating disease |
| JP6670982B2 (ja) * | 2018-03-30 | 2020-03-25 | 生化学工業株式会社 | 生物活性を有するカルボン酸型化合物−ポリマーコンジュゲート及びその製造方法 |
| US10912759B2 (en) * | 2018-05-17 | 2021-02-09 | William Andrew Clark | Topical gel compositions for the treatment of Staphylococcal infections |
| WO2020034987A1 (zh) * | 2018-08-15 | 2020-02-20 | 江苏豪森药业集团有限公司 | 含有葡糖苷酸衍生物jak抑制剂的前药及其制备方法和应用 |
| WO2020092015A1 (en) | 2018-11-02 | 2020-05-07 | University Of Rochester | Therapeutic mitigation of epithelial infection |
| CN110403944A (zh) * | 2019-08-07 | 2019-11-05 | 中南大学湘雅医院 | Decernotinib在制备治疗银屑病的外用药物中的应用、药物及制备方法 |
| WO2021138391A1 (en) | 2019-12-30 | 2021-07-08 | Tyra Biosciences, Inc. | Indazole compounds |
| EP3944859A1 (en) | 2020-07-30 | 2022-02-02 | Assistance Publique Hôpitaux de Paris | Method for treating immune toxicities induced by immune checkpoint inhibitors |
| IL309840A (en) * | 2021-07-20 | 2024-02-01 | Coval Biopharma Shanghai Co Ltd | An external antidialectic coupling compound drug, and a method of preparation therefor and use thereof |
| WO2023039213A1 (en) * | 2021-09-09 | 2023-03-16 | Biora Therapeutics, Inc. | Aqueous formulations of tofacitinib and tofacitinib salts |
| US20250188088A1 (en) * | 2022-02-21 | 2025-06-12 | Onquality Pharmaceuticals China Ltd. | Compound and use thereof |
| CA3259413A1 (en) * | 2022-06-13 | 2023-12-21 | The University Of Queensland | USES OF JAK INHIBITORS IN THE MANAGEMENT OF DEPRESSION AND CENTRAL NERVOUS SYSTEM (CNS) DISEASES ASSOCIATED WITH INFLAMMATION |
| KR20260055465A (ko) * | 2023-08-22 | 2026-04-23 | 프라임 진 테라퓨틱스 컴퍼니 리미티드 | Jak 억제제용 외용 겔 및 그의 사용 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007098611A1 (en) * | 2006-03-03 | 2007-09-07 | Queen's University At Kingston | Compositions for treatment of cancer |
| EP2503888A4 (en) * | 2009-11-23 | 2015-07-29 | Cerulean Pharma Inc | POLYMERS ON CYCLODEXTRINBASIS FOR THERAPEUTIC ADMINISTRATION |
| US9351943B2 (en) * | 2010-07-01 | 2016-05-31 | Matthew T. McLeay | Anti-fibroblastic fluorochemical emulsion therapies |
| WO2012044832A1 (en) * | 2010-09-30 | 2012-04-05 | Fetzer Oliver S | Methods of treating a subject and related particles, polymers and compositions |
| EP2463289A1 (en) * | 2010-11-26 | 2012-06-13 | Almirall, S.A. | Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors |
-
2014
- 2014-05-30 CA CA2913752A patent/CA2913752A1/en not_active Abandoned
- 2014-05-30 WO PCT/US2014/040230 patent/WO2014194195A2/en not_active Ceased
- 2014-05-30 US US14/291,745 patent/US20140357557A1/en not_active Abandoned
- 2014-05-30 JP JP2016517040A patent/JP2016528174A/ja active Pending
- 2014-05-30 AU AU2014273983A patent/AU2014273983A1/en not_active Abandoned
-
2017
- 2017-07-11 US US15/646,584 patent/US20180117168A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Birke et al. | Polypeptoid-block-polypeptide copolymers: Synthesis, characterization, and application of amphiphilic block copolypept (o) ides in drug formulations and miniemulsion techniques | |
| ES2510396T3 (es) | Direccionamiento a células de cáncer usando nanopartículas | |
| CN101541347B (zh) | 药物载体、其合成及其使用方法 | |
| Moore et al. | Multifunctional polymer‐coated carbon nanotubes for safe drug delivery | |
| ES2525257T3 (es) | Composiciones de ciclopolisacárido y de bendamustina | |
| JP2016153410A5 (enExample) | ||
| JP2017511322A5 (enExample) | ||
| JP2015528002A5 (enExample) | ||
| JP2017505104A5 (enExample) | ||
| JP2014531476A5 (enExample) | ||
| JP2011523643A5 (enExample) | ||
| JP2011530597A5 (enExample) | ||
| JP2019523761A5 (enExample) | ||
| JP2001514167A5 (enExample) | ||
| US20220054659A1 (en) | Psma-targeted pamam dendrimers for specific delivery of imaging, contrast and therapeutic agents | |
| JP2010513441A5 (enExample) | ||
| JP2020519676A5 (enExample) | ||
| CN108601952B (zh) | 雷公藤内酯的葡萄糖缀合物、类似物及其用途 | |
| JPWO2012067138A1 (ja) | 新規なシチジン系代謝拮抗剤の高分子誘導体 | |
| CN102174579B (zh) | 可还原降解的梳型高分子基因载体及其制备方法 | |
| US20170042828A1 (en) | Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same | |
| RU2018128032A (ru) | Полимеры на основе циклодекстрина, способы, композиции и применение | |
| JP2016511777A5 (enExample) | ||
| JP2011506296A5 (enExample) | ||
| JP2021504302A5 (enExample) |